American College of Cardiology

From inspiring keynotes to cutting-edge LBCTs to thought-provoking panels, #ACC25 brought together thousands of cardiovascular professionals to learn, connect and advance cardiovascular care worldwide. 🌍 Access 1,000+ presentations on demand from ACC.25 with #ACCAnywhere ➡️ https://bit.ly/3R7LWEQ

Lutheran Hospital in Fort Wayne, IN, has earned #HeartFailure #ACCAccreditation, showing their team’s dedication to improving care processes & advancing ❤️ health for all! Additional accreditation awardees can be found at #FindYourHeartAHome 👉 https://bit.ly/4iMf2Fw

Join #ACCPrev Section on Wednesday, April 9 at 1 p.m. ET for a recap of #ACC25 prevention content and its influence on clinical practice. The webinar will review several key trials and sessions presented during ACC.25. Learn more and register ➡️ https://bit.ly/3FPt6jo #cvPrev

5️⃣ Methodist Healthcare sites are now Chest Pain Center #ACCAccreditation awardees! The ACC applauds these facilities for harnessing the power of collaboration to promote #cvQI. View the latest #FindYourHeartAHome listing 🔎 https://bit.ly/4iMf2Fw

In the latest edition of ACC Cardiology Hour, Valentin Fuster, MD, PhD, MACC, is joined by expert panelists in a dynamic discussion on the top LBCTs released during #ACC25. Don’t miss key takeaways & expert analysis on ALIGN-AR, Evolut Low Risk, & more. https://lnkd.in/e_zexA_6

💡 ACC Chief Innovation Officer Ami Bhatt, MD, FACC, highlights some of the trending sessions and trials focused on artificial intelligence out of #ACC25 in Chicago, including one focused on the use of deep learning and EKGs. Learn more at our #AI resource center: https://bit.ly/4clQOjk 📽️ Plus, watch more ACC Anywhere TV From ACC.25 on #ACCAnywhere here: https://bit.ly/4jlHTAN

ICYMI: The results of the ZENITH trial provide compelling data to support the use of sotatercept in patients with severe #cvPAH, a subgroup that often is viewed as otherwise end-stage. Get the full clinical trial details here: https://bit.ly/42gtFdk #ACC25

ANGPTL-3 inhibition w/ the human monoclonal antibody, SHR-1918, ↘️ serum LDL-C by 22% to 30%, as well as triglyceride levels by 52% to 63%, in pts at moderate or higher risk of #ASCVD, w/ the effect being dose & frequency dependent. More: https://bit.ly/4l9jxfn #ACC25 #JACC

As we wrap up #ACC25, we want to extend a HUGE thank you to all the speakers, attendees, and supporters who made this event so special! 🙌 From inspiring late-breaking clinical trials like SUMMIT and ZENITH, to thought-provoking panels, we’ve all learned, connected, and helped advance cardiovascular care worldwide. 🌎 We’ve celebrated the latest achievements in the field and the inauguration of the next #ACCPresident during the Annual Convocation. 🎉 Keep the celebration going and see you next year in New Orleans for #ACC26! 🎆 Keep following the full meeting coverage here: https://bit.ly/3YcUZIh

A new chapter begins with #ACCPresident Christopher M. Kramer, MD, FACC! 👏👏👏 Congratulations Dr. Kramer! Inspired by a movie classic, he began his #ACC25 Convocation speech with: “Today I want to talk to you about two Fantastic Voyage-Related themes: innovation and mentorship.” Read the full speech here 💬 https://bit.ly/41RJlF6 #ACCLeadership